103 related articles for article (PubMed ID: 11210724)
1. Acetyl-seryl-aspartyl-lysyl-proline is a novel natural cell cycle regulator of renal cells.
Iwamoto N; Xano HJ; Yoshioka T; Shiraga H; Nitta K; Muraki T; Ito K
Life Sci; 2000 Mar; 66(15):PL221-6. PubMed ID: 11210724
[TBL] [Abstract][Full Text] [Related]
2. N-acetyl-seryl-aspartyl-lysyl-proline inhibits diabetes-associated kidney fibrosis and endothelial-mesenchymal transition.
Nagai T; Kanasaki M; Srivastava SP; Nakamura Y; Ishigaki Y; Kitada M; Shi S; Kanasaki K; Koya D
Biomed Res Int; 2014; 2014():696475. PubMed ID: 24783220
[TBL] [Abstract][Full Text] [Related]
3. βklotho is essential for the anti-endothelial mesenchymal transition effects of N-acetyl-seryl-aspartyl-lysyl-proline.
Gao R; Kanasaki K; Li J; Kitada M; Okazaki T; Koya D
FEBS Open Bio; 2019 May; 9(5):1029-1038. PubMed ID: 30972974
[TBL] [Abstract][Full Text] [Related]
4. N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) mitigates the liver fibrosis via WTAP/m
Wei A; Zhao F; Hao A; Liu B; Liu Z
Gene; 2022 Mar; 813():146125. PubMed ID: 34921949
[TBL] [Abstract][Full Text] [Related]
5. Significant decrease in plasma N-acetyl-seryl-aspartyl-lysyl-proline level in patients with end stage renal disease after kidney transplantation.
Suzuki Y; Katagiri F; Sato F; Fujioka K; Sato Y; Fujioka T; Sato Y; Mimata H; Itoh H
Biol Pharm Bull; 2014; 37(6):1075-9. PubMed ID: 24882420
[TBL] [Abstract][Full Text] [Related]
6. Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis.
Srivastava SP; Shi S; Kanasaki M; Nagai T; Kitada M; He J; Nakamura Y; Ishigaki Y; Kanasaki K; Koya D
Sci Rep; 2016 Jul; 6():29884. PubMed ID: 27425816
[TBL] [Abstract][Full Text] [Related]
7. The antiproliferative activity of the tetrapeptide Acetyl-N-SerAspLysPro, an inhibitor of haematopoietic stem cell proliferation, is not mediated by a thymosin beta 4-like effect on actin assembly.
Cheviron N; Grillon C; Carlier MF; Wdzieczak-Bakala J
Cell Prolif; 1996 Aug; 29(8):437-46. PubMed ID: 8918557
[TBL] [Abstract][Full Text] [Related]
8. Source, catabolism and role of the tetrapeptide N-acetyl-ser-asp-lys-Pro within the testis.
Stéphan J; Melaine N; Ezan E; Hakovirta H; Maddocks S; Toppari J; Garnier D; Wdzieczak-Bakala J; Jégou B
J Cell Sci; 2000 Jan; 113 ( Pt 1)():113-21. PubMed ID: 10591630
[TBL] [Abstract][Full Text] [Related]
9. [Role of extracellular signal-regulated kinase 1/2 on inhibition of N-acetyl-seryl-aspartyl-lysyl-proline on proliferation and collagen synthesis of cultured rat pulmonary fibroblasts induced by platelet-derived growth factor].
Wu KF; Fang Y; Li DD; Zhang LJ; Li Q; Wang RM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2009 Jul; 27(7):385-9. PubMed ID: 20039534
[TBL] [Abstract][Full Text] [Related]
10. Clinical Implications of Plasma N-acetyl-seryl-aspartyl-lysyl-proline Level in Stable Kidney Transplant Recipients.
Suzuki Y; Katagiri F; Sato F; Fujioka K; Sato Y; Fujioka T; Sato Y; Mimata H; Itoh H
Clin Lab; 2016 Jul; 62(7):1323-1328. PubMed ID: 28164637
[TBL] [Abstract][Full Text] [Related]
11. Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney disease.
Srivastava SP; Goodwin JE; Kanasaki K; Koya D
Br J Pharmacol; 2020 Aug; 177(16):3691-3711. PubMed ID: 32352559
[TBL] [Abstract][Full Text] [Related]
12. Activity of acetyl-Ser-Asp-Lys-Pro (AcSDKP) on human hematopoietic progenitor cells in short-term and long-term bone marrow cultures.
Jackson JD; Ozerol E; Yan Y; Ewel C; Talmadge JE
J Hematother Stem Cell Res; 2000 Aug; 9(4):489-96. PubMed ID: 10982247
[TBL] [Abstract][Full Text] [Related]
13. [Regulating effect of N-acetyl-seryl-aspartyl-lysyl-proline on activation of c-jun N-terminal kinase pathway in rats with silicosis].
Wei ZQ; Yu WY; Feng HL; Ma WD; Li ZG; Xu H; Wang RM; Yang F
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 May; 31(5):335-40. PubMed ID: 23803521
[TBL] [Abstract][Full Text] [Related]
14. The tetrapeptide AcSDKP, a physiological inhibitor of normal cell proliferation, reduces the S phase entry of continuous cell lines.
Volkov L; Quéré P; Coudert F; Comte L; Praloran V
Exp Cell Res; 1996 Feb; 223(1):112-6. PubMed ID: 8635482
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effects of AcSDKP on proliferation of human bone marrow mesenchymal stem cells in vitro].
Dai G; Huang C; Li Y; Pi YH; Wang BH
Sheng Li Xue Bao; 2006 Apr; 58(2):110-5. PubMed ID: 16628356
[TBL] [Abstract][Full Text] [Related]
16. [Anti-fibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline in lung of rat with silicosis].
Yan JB; Zhang LJ; Li Q
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jul; 26(7):401-5. PubMed ID: 19080377
[TBL] [Abstract][Full Text] [Related]
17. Endothelial FGFR1 (Fibroblast Growth Factor Receptor 1) Deficiency Contributes Differential Fibrogenic Effects in Kidney and Heart of Diabetic Mice.
Li J; Liu H; Srivastava SP; Hu Q; Gao R; Li S; Kitada M; Wu G; Koya D; Kanasaki K
Hypertension; 2020 Dec; 76(6):1935-1944. PubMed ID: 33131311
[TBL] [Abstract][Full Text] [Related]
18. [Effect of N-acetyl-seryl-aspartyl-lysyl-proline on regulation of expression of ras-raf-ERK1/2 signal transduction pathway in lung of rats with silicosis].
Tian JR; Yang F; Li DD; Zhang LJ; Wei ZQ; Feng HL; Li ZG; Wang RM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2010 Oct; 28(10):760-5. PubMed ID: 21126429
[TBL] [Abstract][Full Text] [Related]
19. Renal and metabolic clearance of N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) during angiotensin-converting enzyme inhibition in humans.
Azizi M; Ezan E; Reny JL; Wdzieczak-Bakala J; Gerineau V; Ménard J
Hypertension; 1999 Mar; 33(3):879-86. PubMed ID: 10082503
[TBL] [Abstract][Full Text] [Related]
20. [Anti-fibrotic role of AcSDKP through inhibition of P38MAPK pathway activity mediated transforming growth beta receptors in rat with silicosis].
Wei Z; Sun Y; Cheng H; Ma W; Xu H; Li Q; Zhang L; Wang R; Yang F
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 May; 32(5):340-7. PubMed ID: 25169087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
